Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy.

Bjarnason, Ingvar; Hayllar, Jeremy; Smethurst, Paul; Price, Ashley B.; Gumpel, M.

doi:10.1136/gut.33.9.1204

Cited by 165 publications

(117 citation statements)

References 29 publications

Supporting

Mentioning

108

Contrasting

Unclassified

Order By: Relevance

“…And long-term administration of prophylactic drugs is needed for chronic users of NSAIDs or aspirin, especially patients with experience of small intestinal bleeding. Until recently, some trials showed the efficacy of metronidazole, sulfasalazine, and misoprostol for treatment of NSAID-induced injury [45][46][47]. However, in these studies, efficacy was indirectly evaluated by measuring several markers such as hemoglobin levels and fecal excretion of radiolabeled neutrophils, so their effectiveness has not yet been fully confirmed.…”

Section: Prevention and Treatment Of Small Intestinal Mucosal Injury mentioning

confidence: 99%

Present status and strategy of NSAIDs-induced small bowel injury

et al. 2009

View full text Add to dashboard Cite

Non-steroidal anti-inflammatory drugs (NSAIDs) are well known to cause gastroduodenal mucosal lesions as an adverse effect. Recently, the serious problem of NSAID-induced small intestinal damage has become a topic of great interest to gastroenterologists, since capsule endoscopy and balloon enteroscopy are available for the detection of small intestinal lesions. Such lesions have been of great concern in clinical settings, and their treatment and prevention must be devised as soon as possible. The prevalence of NSAIDs-induced small intestinal injury is higher than had been expected. Recent studies show that more than 50% of patients taking NSAIDs have some mucosal damage in the small intestine. The gross appearance of NSAIDinduced enteropathy varies, appearing variously as diaphragm-like strictures, ulcers, erosions, and mucosal redness. To investigate NSAID-induced enteropathy, and to rule out other specific enteropathies, other useful methods (in addition to capsule endoscopy and balloon enteroscopy) include such modalities as radiological examination of the small intestine, the permeability test, scintigraphy or the fecal excretion test using 111 Indium-labeled white blood cells, and measurement of the fecal calprotectin concentration. Diaphragm-like strictures and bleeding from mucosal breaks may be treatable with interventional enteroscopy. Misoprostol, metronidazole, and sulfasalazine are frequently used to treat NSAID-induced enteropathy, but have undesirable effects in some cases. In the experimental model, we confirmed that several existing drugs for gastroduodenal ulcers prevented indomethacin-induced small intestinal injury. Such drugs may be useful for preventing the adverse effects of NSAIDs not only in the stomach but also in the small intestine. We hope to examine these drugs in future clinical studies.

show abstract

Section: Prevention and Treatment Of Small Intestinal Mucosal Injury mentioning

confidence: 99%

Present status and strategy of NSAIDs-induced small bowel injury

et al. 2009

View full text Add to dashboard Cite

show abstract

“…However, even if temporary cessation of the NSAIDs is possible, long-term cessation of NSAIDs is frequently impossible, and long-term administration of prophylactic drugs is needed for chronic users of NSAIDs or aspirin, especially patients who experience small intestinal bleeding. Some trials have shown the efficacy of metronidazole, sulfasalazine and misoprostol for treatment of NSAIDinduced injury (11)(12)(13). Clinically, proton pump inhibitors (PPIs) and PG analogs are the first-choice drugs for the prevention of NSAID-induced peptic ulcers and bleeding (14).…”

Section: Discussionmentioning

confidence: 99%

Asetil salisilik asit kullanımına bağlı oluşan ileoçekal valv ülserleri ve deformasyonu sonucunda gelişen çekumda çift lümen görünümü

Öztaş¹,

Akdoğan²,

Etık³

et al. 2015

Endoskopi Gastrointestinal

View full text Add to dashboard Cite

The use of non-steroidal anti-inflammatory drugs, especially aspirin, has continued to increase with aging and related cardiovascular diseases. Since their well-known side effect is gastroduodenal mucosal injury, aspirin-induced intestinal damage has also become a growing problem. Herein, we present a case with an advanced anatomical impairment of the ileocecal valve deformation, presumably caused by enteric-coated acetyl salicylic acid induced recurrent ulcers.Keywords: Colonoscopy, intestinal ulcers, enteric-coated acetyl salicylic acid Günümüzde; non steroidal anti-inflamatuvar ilaçlar›n, özellikle aspirinin kullan›m› yafllanma ve yafllanmayla iliflkili kardiyovasküler hastal›klar›n s›kl›¤›n-daki art›flla birlikte giderek artmaktad›r. Aspirinin; gastroduodenal mukozal hasar yap›c› etkisi gibi en iyi bilinen yan etkisinin yan›nda yine aspirin nedeniyle oluflan intestinal hasar da daha s›k karfl›m›za ç›kmaktad›r. Burada muhtemelen enterik-kapl› asetil salisilik asit kullan›m› nedeniyle oluflan rekürran ülserlere ba¤l› geliflen ileoçekal valv deformasyonlu olguyu sunuyoruz.Anahtar kelimeler: Kolonoskopi, intestinal ülserler, enterik-kapl› asetil salisilik asit INTRODUCTIONThe prevalence of non-steroidal anti-inflammatory drugs (NSAIDs) (including aspirin)-induced intestinal injury is higher than had been expected (1). The appearance of NSAIDinduced intestinal injury varies, appearing variously as diaphragm-like strictures, ulcers, erosions, and mucosal redness (2-5). Herein, we present a case with an advanced anatomical impairment of the ileocecal valve deformation, presumably caused by enteric-coated acetyl salicylic acid (EC-ASA)-induced recurrent ulcers. CASE REPORTA 68-year-old male was admitted to the hospital with the complaints of weakness and dyspnea. He had a history of myocardial infarction 12 years ago, and he had been followed until the admission for congestive heart failure. He was still using medications intended for this disease, including 300 mg/day EC-ASA. He did not have any gastrointestinal complaints. On the laboratory examination, deep anemia was determined (hemoglobin: 6.8 g/dl, hematocrit level: 20%, and ferritin level: 2.4 ng/ml). Additionally, occult blood test in the stool examination was found to be positive. Subsequently, upper gastrointestinal endoscopy (revealing pangastritis) and colonoscopy were performed. During colonoscopy, double lumen appearance of the proximal side of the colon was determined ( Figure 1). During the procedure, it was realized that one of the lumens was the base of the cecum (larger arrow #1), and the other was the ileum (larger arrow #2). Both on the mucosa of the terminal ileum and the anatomically disrupted ileocecal valve, multiple ulcers were present (small arrows in Figure 1 and Figure 2). Biopsy specimens taken from the edges of the ulcers were reported as non-specific inflammatory findings. The valve deformation on the cecum resulted in pseudodiverticulum formation (larger arrow #3). Furthermore, two polyps on the cecum determined during colonoscopy we...

show abstract

“…I. Bjarnason и соавт. [54] сообщили, что у больных ревмато-идным артритом, получавших различные НПВП, включая АСК, прием метронидазола в аналогичной дозе привел к снижению выраженности воспаления тонкой кишки. Между тем примене-ние метронидазола ограничено по времени и может иметь само-стоятельное неблагоприятное значение в изменении состава и численности микробиоты кишечника.…”

Section: терапевтический архив 12 2014unclassified

Antiplatelet therapy with acetylsalicylic acid: Approaches to reducing the frequency of gastrointenstinal adverse reactions

Ev¹

2014

Ter. arkh.

View full text Add to dashboard Cite

Антитромбоцитарная терапия (АТТ) ингибитором синтеза тромбоксана А 2 -ацетилсалициловой кислотой (АСК) -высоко эффективна для профилактики сердечно-сосудистых осложне-ний (ССО). Между тем снижение риска развития кардиологиче-ских событий достигается путем повышения вероятности неже-лательных реакций со стороны органов пищеварения.Прием АСК традиционно связывают с поражением прокси-мальных отделов (ПО) желудочно-кишечного тракта (ЖКТ). При длительной терапии низкими дозами АСК частота развития симптомов диспепсии достигает 15-40% [1], эрозивного эзофа-гита -7,9-22%, язв пищевода -0,9% [2,3], эрозий желудка и/ или двенадцатиперстной кишки (ДПК) -34-63,1% [4,5], язв желудка и/или ДПК -10-40% [6]. Относительный риск (ОР) желудочно-кишечных кровотечений (ЖКК) варьирует, по расче-там различных авторов, в пределах от 2,4 до 7,7 [7,8]. Показатель выше в случаях приема АСК для первичной по сравнению с вто-ричной профилактикой ССО [9].Между тем благодаря внедрению в клиническую практику новых методов диагностики появились сведения о поражении АСК дистальных отделов (ДО) пищеварительного тракта. Назна-чение АСК в дозе 100 мг/сут здоровым добровольцам привело через 2 нед к повреждению слизистой оболочки (СО) тонкой АннотацияПрием ацетилсалициловой кислоты (АСК) высокоэффективен для профилактики сердечно-сосудистых осложнений, но сопряжен с повышением вероятности нежелательных явлений со стороны органов пищеварения. В статье представлены современные данные по эпидемиологии, механизмам развития и факторам риска эзофагогастродуодено-и энтеропатий на фоне длительной терапии низкими дозами АСК. Изложены ключевые принципы их профилактики. Ключевые слов: ацетилсалициловая кислота, ингибиторы протонной помпы, эрадикационная терапия.Acetylsalicylic acid (ASA) is highly effective in preventing cardiovascular events, but associated with increased risk for digestive adverse reactions. The paper provides an update on the epidemiology, mechanisms, and risk factors of esophagogastroduodenoand enteropathies during long-term low-dose ACA therapy. It outlines the key principles of their prevention. Key words: acetylsalicylic acid, proton pump inhibitors, eradication therapy.ИМ -инфаркт миокарда НПВП -нестероидные противовоспалительные препараты ОР -относительный риск ОШ -отношение шансов ПО -проксимальные отделы РКИ -рандомизированное клиническое исследование СО -слизистая оболочка ССО -сердечно-сосудистые осложнения ЦОГ-1 -циклооксигеназа-1 ЯБ -язвенная болезнь кишки, визуализированному с помощью капсульной эндоско-пии, в 50% случаев. По сравнению с исходным уровень фекаль-ного кальпротектина (показателя, коррелирующего с гистологи-ческой и эндоскопической активностью воспаления стенки киш-ки) повысился в 4 раза, а коэффициента лактулоза/маннитол (теста на проницаемость кишечной стенки, отражающего ба-рьерную функцию кишечной стенки) -в 1,7 раза [10]. Применяя капсульную эндоскопию для уточнения происхождения ЖКК и/ или болевого абдоминального синдрома у лиц, получавших низ-кие дозы АСК более 3 мес, H. Endo и соавт.[11] в 63,6% случаев выя...

show abstract

Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy.

Cited by 165 publications

References 29 publications

Present status and strategy of NSAIDs-induced small bowel injury

Present status and strategy of NSAIDs-induced small bowel injury

Asetil salisilik asit kullanımına bağlı oluşan ileoçekal valv ülserleri ve deformasyonu sonucunda gelişen çekumda çift lümen görünümü

Antiplatelet therapy with acetylsalicylic acid: Approaches to reducing the frequency of gastrointenstinal adverse reactions

Contact Info

Product

Resources

About